Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Guerbet
Guerbet CCO David Hale Lined Up As New Company CEO
Guerbet announced its chief commercial officer will take over as CEO in January 2020. David Hale will lead the imaging company as it steps up its growth strategy, called Gear 2023.
Guerbet Targets Multi-Use Markets To Grow Diagnostic Imaging Biz
French imaging agent specialist Guerbet is targeting multi-use markets to grow its diagnostic imaging business while continuing to build through acquisitions. While its diagnostic imaging revenues were about flat in 2018, its imaging intervention business grew almost 19% in constant currency compared to 2017.
Venture Funding Deals: BioNTech's Big Money Leads January Financings
BioNTech's $270m Series A round was the biggest start-up financing in January, but sizeable rounds also were raised by Centrexion ($67m), Eureka ($60m) and Pandion ($58m).
GBCA Sponsors Must Conduct Human, Animal Studies To Assess Safety
US FDA is requiring additional safety measures related to GBCAs, but holds that there is no direct relationship established between gadolinium retention and kidney function.
- Radiopharmaceuticals, Contrast Agents
Diagnostic Imaging Equipment & Supplies
- MRI, NMR
- Diagnostic Imaging Equipment & Supplies
- Other Names / Subsidiaries
- Accurate Medical Therapeutics, Ltd
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.